Trial intelligence / Profile preview

Transdermal medical cannabis for painful diabetic peripheral neuropathy

TCTR20211220008Phase 3Not yet recruiting

Sponsor
Faculty of Medicine, Khon Kaen University
Start
Feb 2022
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of nabiximols in diabetic polyneuropathy (DPN), sponsored by Faculty of Medicine, Khon Kaen University. Planned start Feb 2022; status: not yet recruiting.

02

Drugs

nabiximols
03

Conditions

diabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on TCTR20211220008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20211220008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call